Format

Send to

Choose Destination
Nat Neurosci. 2001 Oct;4(10):981-8.

Neurotrophins use the Erk5 pathway to mediate a retrograde survival response.

Author information

1
Department of Neurobiology, Harvard Medical School, Dana 620, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Erratum in

  • Nat Neurosci 2002 Oct;5(10):1017.

Abstract

Growth factors synthesized and released by target tissues promote survival and differentiation of innervating neurons. This retrograde signal begins when growth factors bind receptors at nerve terminals. Activated receptors are then endocytosed and transported through the axon to the cell body. Here we show that the mitogen-activated protein kinase (MAPK) signaling pathways used by neurotrophins during retrograde signaling differ from those used following direct stimulation of the cell soma. During retrograde signaling, endocytosed neurotrophin receptors (Trks) activate the extracellular signal-related protein kinase 5 (Erk5) pathway, leading to nuclear translocation of Erk5, phosphorylation of CREB, and enhanced neuronal survival. In contrast, Erk1/2, which mediates nuclear responses following direct cell body stimulation, does not transmit a retrograde signal. Thus, the Erk5 pathway has a unique function in retrograde signaling. Differential activation of distinct MAPK pathways may enable an individual growth factor to relay information that specifies the location and the nature of stimulation.

PMID:
11544482
DOI:
10.1038/nn720
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center